EDIT FY 2024 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$32M-58.6% YoY

Gross Profit

$32M100.0% margin

Operating Income

-$251M-777.2% margin

Net Income

-$237M-733.7% margin

EPS (Diluted)

$-2.88

Cash Flow

Operating Cash Flow

-$210M

Free Cash Flow

-$219M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$342M

Total Liabilities

$207M

Stockholders' Equity

$134M

Cash & Equivalents

$132M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$78M	-58.6%
Gross Profit	$32M	$72M	-55.2%
Operating Income	-$251M	-$169M	-48.5%
Net Income	-$237M	-$153M	-54.7%